The global patient generated health data market size was valued at US$ 5.80 Bn in 2023 and is expected to reach US$ 19.06 Bn by 2030, growing at a Compound Annual Growth Rate (CAGR) of 18.5% from 2023 to 2030.
Patient Generated Health Data Market Regional Insights
North America has been the dominant region in the patient generated health data market for several years. The large size of the U.S. healthcare industry and the presence of key technology players have been major drivers for the region. Furthermore, high healthcare expenditure per capita and an established legislative environment enabling patient engagement efforts have enabled technology to collect health data directly from patients to thrive. Several large hospitals and health systems have incorporated patient portals and apps, allowing patients to track vital metrics and log symptoms at home. This has streamlined care delivery and management across provider networks. Rising demand for accountability in healthcare outcomes is also prompting providers to leverage patient insights for quality improvements and value-based reimbursements.
The Europe market is witnessing robust growth and emerges as the second-largest owing to the rising prevalence of chronic conditions like cardiovascular diseases, diabetes, and respiratory illnesses among the aging population. This has prompted healthcare systems to shift focus from hospital-centered to preventive and home-based care. Remote monitoring of vitals, symptoms, and treatment adherence for conditions like heart disease allows clinicians to proactively react proactively in crises or identify high-risk patients earlier. Countries like the U.K., Germany, Spain, and Italy have seen large deployments of remote monitoring devices and platforms that generate extensive disease management datasets.
Asia Pacific has emerged as the fastest-growing regional market. Countries like China, Japan, and India are investing heavily in digital health technologies to meet the evolving needs of their burgeoning patient populations. Favorable government policies supporting telehealth and remote patient monitoring are accelerating adoption. In addition, the increasing burden of chronic diseases and rising healthcare costs are compelling payors and providers to optimize resource usage. This has boosted the adoption of technologies that facilitate early disease detection and prevention of expensive hospital visits through remote patient engagement. Large Asian companies have also entered the patient engagement technology space and are launching affordable solutions to address middle-income population segments. Additionally, many Asian countries have younger demographics that are rapidly embracing consumer-focused digital health and wellness tools.
Figure 1. Global Patient Generated Health Data Market Share (%), By Region, 2023
To learn more about this report, request a free sample copy
Analyst View
The patient generated health data market is positioned for strong growth over the next five years. One of the key drivers propelling this space is the shift towards patient-centric healthcare models. As patients become more involved in managing their own health, capturing their subjective health data will become increasingly important. Another factor is the growing ubiquity of wearable devices and connected health technologies. More patients will adopt these tools to track metrics like activity, sleep, and vitals outside clinical settings. However, data privacy remains a restraint for this industry. Patients continue to be wary of how their personal health data is collected and shared. Establishing transparency and consent over data usage will be critical for companies. Interoperability between disparate systems capturing patient data also poses a challenge for deriving meaningful insights.
The opportunities lie in leveraging real-world data to support drug development, clinical trial recruitment, and care coordination. Startups are emerging with novel approaches to integrating patient inputs into care pathways for chronic conditions. Telehealth will play a bigger role by facilitating remote monitoring. Over time, artificial intelligence could help extract value from the growing volumes of unstructured patient data. Geographically, North America currently dominates due to the greater prevalence of digital health adoption by patients and providers. But Asia-Pacific is anticipated to demonstrate faster growth as mobile health usage expands in densely populated regions.
Patient Generated Health Data Market Drivers:
- Increased patient engagement and awareness: One of the key drivers for the patient generated health data market is the increased engagement and awareness among patients about their health conditions. With the rise of digital health tools and wearable devices, patients are more proactively tracking metrics like activity levels, sleep, vital signs, and other biometric data. They want visibility into their health numbers on an ongoing basis, which empowers them to play a bigger role in managing chronic conditions. Wearables and mobile apps offer an easy way for patients to collect a wide variety of personal health data with minimal effort. This self-tracking trend is driving many patients to adopt tools and services that give them centralized access to their data in one place.
- Transition towards value-based care is incentivizing data sharing: Another major market driver is the ongoing transformation in healthcare payment models towards value-based arrangements. Here, providers are taking on increased financial risk and are ultimately paid based on patient health outcomes rather than fee-for-service volumes. This shift is incentivizing providers to leverage patient-generated data to gain deeper insights into overall population health and identify opportunities for preventative interventions. It allows them to track the effectiveness of care plans, make adjustments accordingly, and improve outcomes over time. The move to value-based care models is thus encouraging both patients and providers to be more open with data sharing so that insights can be applied to enhance care coordination and quality.
- Growing prevalence of chronic diseases: The growing prevalence of chronic diseases across the world is one of the key factors fueling the growth of the patient generated health data market. Chronic diseases such as diabetes, cardiovascular diseases, cancer, etc. have been on the rise over the past few decades owing to shifting lifestyle trends such as unhealthy diet, a lack of physical activity, rising obesity rates, and growing environmental pollution levels. As per the World Health Organization (WHO) data, chronic diseases accounted for over 70% of all deaths globally in 2020. Managing chronic diseases requires long-term care, regular monitoring of vitals and symptoms, and adherence to medication and treatment plans. This is driving increased reliance on patient-centric care where individuals are playing a more proactive role in managing their health conditions. Patients are increasingly self-monitoring health parameters like blood sugar, blood pressure, weight, physical activity levels etc. using various digital health tools such as wearables, health apps, and connected devices at home.
Patient Generated Health Data Market Opportunities:
- Integration of wearables and remote patient monitoring devices: The integration of wearable devices and remote patient monitoring systems provides a great opportunity in the patient generated health data market. Wearable devices such as smartwatches and fitness trackers allow patients to easily monitor their vital signs, activity levels, and other health metrics from the convenience of their home. This removes the need for frequent in-office visits and empowers patients to play a more proactive role in managing their own care. The data collected from these devices can be seamlessly shared with care providers through digital platforms. This enables remote monitoring of chronic conditions and speedy detection of any deviations from normal health patterns. Remote monitoring technologies allow high-risk patients, especially those in rural areas far from hospitals, to be effectively tracked. They reduce disease exacerbations and prevent unnecessary emergency room visits or hospitalizations through timely interventions. This proves highly beneficial from the perspectives of both improved patient outcomes and cost savings for overburdened healthcare systems.
- Increasing initiatives by pharmaceutical industries to collect patient feedback: Patient generated health data has become increasingly important for pharmaceutical companies to gain valuable insights into the patient experience. With more initiatives to collect direct feedback from patients, it presents a great opportunity for the market to grow. Pharmaceutical companies are now recognizing that understanding how patients function and live with their conditions can provide crucial information to aid drug development and the improvement of existing treatments. Direct patient reported outcomes and experiences can give insights into symptom progressions, side effects, medication adherence, and other real-world factors outside of controlled clinical trials. This helps ensure treatments actually improve patients' quality of life and address their true needs. Many companies have launched programs and digital platforms for patients to regularly report on their health status, symptoms, and treatment journey.
Global Patient Generated Health Data Market Report Coverage
| Report Coverage |
Details |
|---|
| Base Year: |
2022 |
Market Size in 2023: |
US$ 5.80 Bn |
|---|
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
|---|
| Forecast Period 2023 to 2030 CAGR: |
18.5% |
2030 Value Projection: |
US$ 19.06 Bn |
|---|
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|
| Segments covered: |
- By Data Type: Fitness & wellness data, Disease management data, Remote monitoring data, Others
- By End User: Hospitals & clinics, Research centers, Healthcare payers, Others
|
| Companies covered: |
Apple Inc., Fitbit, Inc., Dexcom, Inc., Medtronic plc, Omada Health, Inc., Propeller Health, AliveCor, Inc., WellDoc, Inc., Noom, Inc., Livongo Health, HealthMine, Inc., Epic Systems Corporation, Allscripts Healthcare Solutions, Cerner Corporation and Athenahealth, Inc.
|
| Growth Drivers: |
- Increased Patient Engagement And Awareness
- Transition Towards Value-Based Care Is Incentivizing Data Sharing
- Growing Prevalence Of Chronic Diseases
|
| Restraints & Challenges: |
- Interoperability Challenges Limit Data Integration
- Security And Privacy Concerns Discourage Adoption
|
Patient Generated Health Data Market Trends:
- Cloud-based patient-generated health solutions: Cloud-based patient-generated health data solutions are having a significant influence on the patient generated health data market. As healthcare increasingly moves to digital platforms, patients are now able to easily capture and share diverse health data beyond what is typically recorded in medical records. Cloud technologies are enabling the seamless integration of various remote monitoring devices, wearables, apps, and digital engagement platforms to aggregate longitudinal patient health data over time. This trend towards centralized cloud-based repositories of patient data is empowering individuals to take a more active role in their own care. Patients can share their unique health history and generated data with their care teams to enhance clinical discussions and inform care planning decisions. It is also improving care coordination across different providers.
- Advent of electronic health records (EHRs): The advent of electronic health records (EHRs) has significantly influenced the patient generated health data market in recent years. As more healthcare providers adopt digital systems that allow patients to access their medical records online, it has empowered individuals to actively monitor and track different health parameters outside of traditional clinical settings. Patients can now easily share a variety of data points, such as blood sugar readings, blood pressure, weight, symptoms, medication intake, and activity levels, with their doctors through EHR portals or dedicated mobile applications. This trend of patient-driven data collection and reporting has provided two major benefits. Firstly, it gives providers deeper insights into an individual's health history beyond what can be gathered from intermittent office visits. Longitudinal tracking of key vitals outside of clinical examinations helps capture more accurate health trends over time and aids in the early detection of potential issues or fluctuations. Secondly, active data sharing by patients has been found to encourage greater engagement with their own care.
Patient Generated Health Data Market Restraints:
- Interoperability challenges limit data integration: One key restraint hampering the growth of the patient generated health data market is the lack of interoperability between various solutions and health IT systems. Siloed systems, disparate data formats, and the absence of common standards make it difficult to pool and analyze patient data from multiple sources. This means that providers often cannot access valuable insights from self-tracking tools, fitness monitors, and other personal devices. Resolving issues around semantic interoperability and obtaining central access to heterogeneous datasets continues to be a challenge that restricts how patient-generated information can be integrated into care pathways.
- Security and privacy concerns discourage adoption: Patient privacy and data security are also barriers constraining market expansion. Breaches can expose patients to the risks of identity theft, insurance discrimination, and other harmful outcomes. Ensuring robust safeguards, transparency in data usage policies, and empowering patients over their personal information remains crucial to addressing these apprehensions. Without tackling such trust deficits, adoption of patient-generated tools and participation in data sharing initiatives may continue to be limited.
Recent Developments
Product Launches
- In January 2023, the World Health Organization (WHO) announced the launch of the publicly accessible global individual patient data (IPD) platform for tuberculosis treatment (TB-IPD), an initiative that will expand the knowledge base for normative guidance on optimal tuberculosis (TB) treatment modalities and stimulate TB research. Over 5,000 TB patients' individual records with treatment results are already stored on this safe platform.
- In October 2022, Panda Health Inc., a digital health marketplace, announced the launch of new categories aimed at assisting hospitals and health systems in providing a full continuum of patient care through health at home programs. The Remote Patient Monitoring (RPM), Hospital at Home, and Telehealth solution categories accessible on Panda's marketplace will range from light-touch virtual visits to more in-depth acute care services in the home.
- In January 2022, Temedica GmbH, a major provider of digital health and data analytics, announced the launch of Permea. Permea is a one-of-a-kind platform that provides medically sound analysis and actionable answers to a wide variety of problems and difficulties that arise throughout the healthcare value chain. Permea gives fresh insights into medicines and their effects in real-world situations for the first time by merging regulatory-grade, patient-generated data with a number of freely available scientific and commercial data sources.
Business Development Activities by Market Players
- In November 2023, AstraZeneca, a global biotechnology company, launched Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators, and patients. With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sectors.
- In March 2023, agilon health, a health care technology company, announced the acquisition of mphrX, a provider of value-based care technology and interoperability solutions. As a result of the transaction, mphrX will become a fully owned subsidiary of agilon health.
- In August 2021, GE Healthcare, a worldwide medical technology company, announced a strategic partnership with Amazon Web Services (AWS), a subsidiary of Amazon that provides on-demand cloud computing platforms, to provide hospitals and healthcare providers with AI and cloud-based imaging solutions, integrated data, and clinical and operational insights. GE Healthcare intends to offer its AI-based imaging applications and Edison Health Services platform on AWS, positioning the company to lead the way in assisting healthcare providers worldwide in transitioning from the traditional care delivery model provided in the hospital setting to a more decentralized, virtual, and distributed model.
Figure 2. Global Patient Generated Health Data Market Share (%), By Data Type, 2023
To learn more about this report, request a free sample copy
Top Companies in the Patient Generated Health Data Market
- Apple Inc.
- Fitbit, Inc.
- Dexcom, Inc.
- Medtronic plc
- Omada Health, Inc.
- Propeller Health
- AliveCor, Inc.
- WellDoc, Inc.
- Noom, Inc.
- Livongo Health
- HealthMine, Inc.
- Epic Systems Corporation
- Allscripts Healthcare Solutions
- Cerner Corporation
- Athenahealth, Inc.
Definition:
Patient generated health data is a collection of data recorded and measured directly by patients outside of traditional clinical settings. This type of data provides valuable insights into a patient's health that cannot be obtained through brief clinical visits alone. There are two main types of patient generated health data: data recorded through tools and devices, and data provided directly by patients. Data recorded through tools and devices, includes readings from connected devices that patients use to track and monitor their health at home. This includes devices that measure vital signs like weight scales, blood pressure cuffs, glucometers, and activity trackers. It also includes tools that allow patients to conveniently collect other health metrics over time, like symptoms, diet, medications, and more, through mobile apps or web portals.
U.S.: 
U.K. : 
India :